1887

Abstract

(JEV), a single-stranded positive-sense RNA virus of the family , is the major cause of paediatric encephalitis in Asia. The high incidence of subclinical infections in Japanese encephalitis-endemic areas and subsequent evasion of encephalitis points to the development of immune responses against JEV. Humoral responses play a central role in protection against JEV; however, cell-mediated immune responses contributing to this end are not fully understood. The structural envelope (E) protein, the major inducer of neutralizing antibodies, is a poor target for T cells in natural JEV infections. The extent to which JEV non-structural proteins are targeted by T cells in subclinically infected healthy children would help to elucidate the role of cell-mediated immunity in protection against JEV as well as other flaviviral infections. The property of the Tat peptide of to transduce proteins across cell membranes, facilitating intracellular protein delivery following exogenous addition to cultured cells, prompted us to express the four largest proteins of JEV, comprising 71 % of the JEV genome coding sequence, as Tat fusions for enumerating the frequencies of virus-specific CD4 and CD8 T cells in JEV-immune donors. At least two epitopes recognized by distinct HLA alleles were found on each of the non-structural proteins, with dominant antiviral Th1 T cell responses to the NS3 protein in nearly 96 % of the cohort. The data presented here show that non-structural proteins are frequently targeted by T cells in natural JEV infections and may be efficacious supplements for the predominantly antibody-eliciting E-based JEV vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19531-0
2004-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/2/vir850471.html?itemId=/content/journal/jgv/10.1099/vir.0.19531-0&mimeType=html&fmt=ahah

References

  1. Aihara H., Takasaki T., Matsutani T., Suzuki R., Kurane I. 1998; Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J Virol 72:8032–8036
    [Google Scholar]
  2. Becker-Hapak M., McAllister S. S., Dowdy S. F. 2001; TAT-mediated protein transduction into mammalian cells. Methods 24:247–256
    [Google Scholar]
  3. Chen H. W., Pan C. H., Liau M. Y., Jou R., Tsai C. J., Wu H. J., Lin Y. L., Tao M. H. 1999; Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J Virol 73:10137–10145
    [Google Scholar]
  4. Chisari F. V. 1997; Cytotoxic T cells and viral hepatitis. J Clin Invest 99:1472–1477
    [Google Scholar]
  5. Co M. D., Terajima M., Cruz J., Ennis F. A., Rothman A. L. 2002; Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293:151–163
    [Google Scholar]
  6. Desai A., Ravi V., Chandramuki A., Gourie-Devi M. 1995; Proliferative response of human peripheral blood mononuclear cells to Japanese encephalitis virus. Microbiol Immunol 39:269–273
    [Google Scholar]
  7. Diepolder H. M., Zachoval R., Hoffmann R. M., Wierenga E. A., Santantonio T., Jung M. C., Eichenlaub D., Pape G. R. 1995; Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007
    [Google Scholar]
  8. Hoke C. H., Nisalak A., Sangawhipa N. 8 other authors 1988; Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319:608–614
    [Google Scholar]
  9. Katial R. K., Sachanandani D., Pinney C., Lieberman M. M. 1998; Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts. Clin Diagn Lab Immunol 5:78–81
    [Google Scholar]
  10. Kimura-Kuroda J., Yasui K. 1988; Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 141:3606–3610
    [Google Scholar]
  11. Konishi E., Kurane I., Mason P. W., Innis B. L., Ennis F. A. 1995; Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am J Trop Med Hyg 53:278–283
    [Google Scholar]
  12. Konishi E., Kurane I., Mason P. W., Shope R. E., Kanesa-Thasan N., Smucny J. J., Hoke C. H., Ennis F. A. 1998; Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine 16:842–849
    [Google Scholar]
  13. Konishi E., Yamaoka M., Khin-Sane-Win, Kurane I., Takada K., Mason P. W. 1999; The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J Virol 73:5527–5534
    [Google Scholar]
  14. Konishi E., Yamaoka M., Kurane I., Mason P. W. 2000; Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine. Virology 268:49–55
    [Google Scholar]
  15. Ku C. C., King C. C., Lin C. Y., Hsu H. C., Chen L. Y., Yueh Y. Y., Chang G. J. 1994; Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children. J Med Virol 44:122–131
    [Google Scholar]
  16. Kumar P., Satchidanandam V. 2000; Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood. Clin Diagn Lab Immunol 7:578–583
    [Google Scholar]
  17. Kumar P., Amara R. R., Challu V. K., Chadda V. K., Satchidanandam V. 2003a; The apa protein of Mycobacterium tuberculosis stimulates gamma interferon-secreting CD4+ and CD8+ T cells from purified protein derivative-positive individuals and affords protection in a guinea pig model. Infect Immun 71:1929–1937
    [Google Scholar]
  18. Kumar P., Uchil P. D., Sulochana P., Nirmala G., Chandrashekar R., Haridattatreya M., Satchidanandam V. 2003b; Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch Virol 148:1569–1591
    [Google Scholar]
  19. Kurane I., Brinton M. A., Samson A. L., Ennis F. A. 1991; Dengue virus-specific, human CD4+ CD8 cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 65:1823–1828
    [Google Scholar]
  20. Kurane I., Okamoto Y., Dai L. C., Zeng L. L., Brinton M. A., Ennis F. A. 1995; Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8 cytotoxic T lymphocyte clones. J Gen Virol 76:2243–2249
    [Google Scholar]
  21. Lechner F., Gruener N. H., Urbani S. 8 other authors 2000; CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30:2479–2487
    [Google Scholar]
  22. Lin Y. L., Chen L. K., Liao C. L., Yeh C. T., Ma S. H., Chen J. L., Huang Y. L., Chen S. S., Chiang H. Y. 1998; DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72:191–200
    [Google Scholar]
  23. Livingston P. G., Kurane I., Dai L. C., Okamoto Y., Lai C. J., Men R., Karaki S., Takiguchi M., Ennis F. A. 1995; Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol 154:1287–1295
    [Google Scholar]
  24. Mathew A., Kurane I., Rothman A. L., Zeng L. L., Brinton M. A., Ennis F. A. 1996; Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest 98:1684–1691
    [Google Scholar]
  25. Mathew A., Kurane I., Green S. 7 other authors 1998; Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol 72:3999–4004
    [Google Scholar]
  26. Mathur A., Arora K. L., Chaturvedi U. C. 1983; Host defence mechanisms against Japanese encephalitis virus infection in mice. J Gen Virol 64:805–811
    [Google Scholar]
  27. McMichael A. J., Rowland-Jones S. L. 2001; Cellular immune responses to HIV. Nature 410:980–987
    [Google Scholar]
  28. Miura K., Onodera T., Nishida A., Goto N., Fujisaki Y. 1990; A single gene controls resistance to Japanese encephalitis virus in mice. Arch Virol 112:261–270
    [Google Scholar]
  29. Mosmann T. R., Sad S. 1996; The expanding role of T cells with Th1, Th2 and more. Immunol Today 17:138–146
    [Google Scholar]
  30. Murali-Krishna K., Ravi V., Manjunath R. 1996; Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J Gen Virol 77:705–714
    [Google Scholar]
  31. Pan C. H., Chen H. W., Huang H. W., Tao M. H. 2001; Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J Virol 75:11457–11463
    [Google Scholar]
  32. Poland J. D., Calisher C. H., Monath T. P., Downs W. G., Murphy K. 1981; Persistence of neutralizing antibody 30–35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 59:895–900
    [Google Scholar]
  33. Rao-Bhau L. N., Singh G., Gowal D., Saxena S. N., Kobayashi M., Oya A., Yoshioka I. 1988; Safety & efficacy of Japanese encephalitis vaccine produced in India. Indian J Med Res 88:301–307
    [Google Scholar]
  34. Schwarze S. R., Hruska K. A., Dowdy S. F. 2000; Protein transduction: unrestricted delivery into all cells?. Trends Cell Biol 10:290–295
    [Google Scholar]
  35. Shedlock D. J., Shen H. 2003; Requirement for CD4+ T cell help in generating functional CD8 T cell memory. Science 300:337–339
    [Google Scholar]
  36. Shibagaki N., Udey M. C. 2002; Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 168:2393–2401
    [Google Scholar]
  37. Ting S. H., See E., Tan H. C., Lee M. A., Ooi E. E. 2001; Development of a simplified assay for the detection of neutralizing antibodies to Japanese encephalitis virus. J Virol Methods 93:43–47
    [Google Scholar]
  38. Tsai T. F., Chang G. J., Yu Y. X. 1999; Japanese encephalitis vaccines. In Vaccines , 3rd edn. pp  672–710 Edited by Plotkins S. A., Orenstein W. A. Philadelphia: W. B. Saunders;
    [Google Scholar]
  39. Zeng L., Kurane I., Okamoto Y., Ennis F. A., Brinton M. A. 1996; Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J Virol 70:3108–3117
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19531-0
Loading
/content/journal/jgv/10.1099/vir.0.19531-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error